Infinity Pharmaceuticals, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Infinity Pharmaceuticals, Inc. reported Net Income (Loss) Available to Common Stockholders, Basic of -$11.42 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-10-30.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2019-10-30
- Infinity Pharmaceuticals, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2019-09-30 was -$11.42M, a 186.82% decline year-over-year.
- Infinity Pharmaceuticals, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2018-09-30 was $13.15M.
- Infinity Pharmaceuticals, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2017-09-30 was -$7.10M.
- Infinity Pharmaceuticals, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2017-06-30 was -$16.95M, a 132.64% decline year-over-year.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month |
|---|---|---|---|
| 2019-09-30 | -$11.42M 10-Q · filed 2019-10-30 | -$35.67M 10-Q · filed 2019-10-30 | |
| 2018-09-30 | $13.15M 10-Q · filed 2019-10-30 | -$3.03M 10-Q · filed 2019-10-30 | |
| 2017-09-30 | -$7.10M 10-Q · filed 2018-11-05 | -$24.06M derived: sum of 2 quarters · filed 2018-11-05 | -$34.53M 10-Q · filed 2018-11-05 |
| 2017-06-30 | -$16.95M 10-Q · filed 2017-08-03 | -$27.43M 10-Q · filed 2017-08-03 | |
| 2016-09-30 | -$19.50M 10-Q · filed 2016-11-09 | $32.44M derived: sum of 2 quarters · filed 2017-08-03 | -$7.17M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $51.94M 10-Q · filed 2017-08-03 | $12.08M 10-Q · filed 2017-08-03 | |
| 2015-09-30 | $41.70M 10-Q · filed 2016-11-09 | $3.27M derived: sum of 2 quarters · filed 2016-11-09 | -$89.19M 10-Q · filed 2016-11-09 |
| 2015-06-30 | -$38.43M 10-Q · filed 2016-08-09 | -$131.73M 10-Q · filed 2016-08-09 | |
| 2014-09-30 | $101.14M 10-Q · filed 2015-11-05 | $22.56M 10-Q · filed 2015-11-05 | |
| 2013-09-30 | -$33.94M 10-Q · filed 2014-11-10 | -$93.86M 10-Q · filed 2014-11-10 |